Is n-terminal C-type natriuretic propeptide associated with the endosteal apposition of bone in females with a persistent eating disorder?
NT-proCNP reflects metaphyseal inwaisting which is modified by estrogens and the pressure on the growth plate.
Rifaximin 1200 mg/day for 10 days reduced gastrointestinal symptoms in patients with IBS. Patients with incomplete symptom resolution may respond to increased doses of rifaximin.